Xin Li, Ryan P Kopp, William D Rooney, Charles S Springer, Fergus V Coakley, Mark G Garzotto
{"title":"Trans-cytolemmal water exchange in prostate manifest via DCE-MRI.","authors":"Xin Li, Ryan P Kopp, William D Rooney, Charles S Springer, Fergus V Coakley, Mark G Garzotto","doi":"10.1007/s10334-026-01345-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the potential of the unidirectional cellular water efflux rate constant (k<sub>io</sub>) from DCE-MRI data in prostate MR imaging.</p><p><strong>Materials and methods: </strong>High-temporal-resolution prostate DCE-MRI data were modeled using both the fast-exchange-limit (FXL) Tofts' model as well as the water-exchange-sensitized shutter-speed model (SSM). In the SSM, k<sub>io</sub> was included as an additional fitting parameter. Lesion and normal-appearing (NA) prostate tissue region-of-interest (ROI) data were analyzed and categorized into FXL or non-FXL conditions based on results from the two models. A global upper limit of k<sub>io</sub> detectable by prostate DCE-MRI with the SSM was presented.</p><p><strong>Results: </strong>While many lesion voxels exhibited sensitivity to k<sub>io</sub> with the SSM, a substantial portion remained in the FXL condition despite greater contrast agent extravasation than in NA tissue. The fraction of FXL voxels was higher in lesions than in NA tissue. Applying a global detectable k<sub>io</sub> upper limit increased the difference between lesion and NA ROIs, improving lesion characterization.</p><p><strong>Discussion: </strong>SSM-derived FXL and non-FXL contrasts may serve as novel imaging biomarkers for prostate cancer surveillance. Advances in MRI technology and more potent contrast agents are expected to enhance the accuracy of k<sub>io</sub> quantification, potentially enabling its integration into clinical mpMRI.</p>","PeriodicalId":18067,"journal":{"name":"Magnetic Resonance Materials in Physics, Biology and Medicine","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magnetic Resonance Materials in Physics, Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10334-026-01345-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the potential of the unidirectional cellular water efflux rate constant (kio) from DCE-MRI data in prostate MR imaging.
Materials and methods: High-temporal-resolution prostate DCE-MRI data were modeled using both the fast-exchange-limit (FXL) Tofts' model as well as the water-exchange-sensitized shutter-speed model (SSM). In the SSM, kio was included as an additional fitting parameter. Lesion and normal-appearing (NA) prostate tissue region-of-interest (ROI) data were analyzed and categorized into FXL or non-FXL conditions based on results from the two models. A global upper limit of kio detectable by prostate DCE-MRI with the SSM was presented.
Results: While many lesion voxels exhibited sensitivity to kio with the SSM, a substantial portion remained in the FXL condition despite greater contrast agent extravasation than in NA tissue. The fraction of FXL voxels was higher in lesions than in NA tissue. Applying a global detectable kio upper limit increased the difference between lesion and NA ROIs, improving lesion characterization.
Discussion: SSM-derived FXL and non-FXL contrasts may serve as novel imaging biomarkers for prostate cancer surveillance. Advances in MRI technology and more potent contrast agents are expected to enhance the accuracy of kio quantification, potentially enabling its integration into clinical mpMRI.
期刊介绍:
MAGMA is a multidisciplinary international journal devoted to the publication of articles on all aspects of magnetic resonance techniques and their applications in medicine and biology. MAGMA currently publishes research papers, reviews, letters to the editor, and commentaries, six times a year. The subject areas covered by MAGMA include:
advances in materials, hardware and software in magnetic resonance technology,
new developments and results in research and practical applications of magnetic resonance imaging and spectroscopy related to biology and medicine,
study of animal models and intact cells using magnetic resonance,
reports of clinical trials on humans and clinical validation of magnetic resonance protocols.